121 related articles for article (PubMed ID: 23484337)
1. Severe cutaneous adverse reactions due to isoniazid in a HIV positive patient.
Viswanath BK; Ranka P; Ramanjanayalu M
Indian J Lepr; 2012; 84(3):227-32. PubMed ID: 23484337
[TBL] [Abstract][Full Text] [Related]
2. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
[TBL] [Abstract][Full Text] [Related]
3. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
4. [A case of antitubercular drug-induced toxic epidermal necrosis in a systemic lupus erythematosus patient during treatment for pulmonary tuberculosis].
Sato Y; Murata K; Sasaki A; Wada A; Kato Y; Takamori M
Kekkaku; 2014 Nov; 89(11):807-12. PubMed ID: 25730949
[TBL] [Abstract][Full Text] [Related]
5. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cutaneous drug eruptions in adult Nigerians with HIV/AIDS.
Salami TA; Asalu AF; Samuel SO
Niger Postgrad Med J; 2010 Jun; 17(2):160-3. PubMed ID: 20539333
[TBL] [Abstract][Full Text] [Related]
7. Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases.
Lehloenya RJ; Muloiwa R; Dlamini S; Gantsho N; Todd G; Dheda K
J Antimicrob Chemother; 2015 Sep; 70(9):2648-51. PubMed ID: 26142408
[TBL] [Abstract][Full Text] [Related]
8. Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.
Lehloenya RJ; Wallace J; Todd G; Dheda K
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1260-4. PubMed ID: 22747953
[TBL] [Abstract][Full Text] [Related]
9. A rare case of streptomycin-induced toxic epidermal necrolysis in a patient with tuberculosis: a therapeutic dilemma.
Hmouda H; Laouani-Kechrid C; Nejib Karoui M; Denguezli M; Nouira R; Ghannouchi G
Ann Pharmacother; 2005 Jan; 39(1):165-8. PubMed ID: 15546942
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid associated, painful, bilateral gynaecomastia.
Khanna P; Panjabi C; Maurya V; Shah A
Indian J Chest Dis Allied Sci; 2003; 45(4):277-9. PubMed ID: 12962465
[TBL] [Abstract][Full Text] [Related]
11. Fatal toxic epidermal necrolysis associated with minoxidil.
Karaoui LR; Chahine-Chakhtoura C
Pharmacotherapy; 2009 Apr; 29(4):460-7. PubMed ID: 19323621
[TBL] [Abstract][Full Text] [Related]
12. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
[TBL] [Abstract][Full Text] [Related]
13. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.
Lehloenya RJ; Todd G; Wallace J; Ngwanya MR; Muloiwa R; Dheda K
Br J Dermatol; 2016 Jul; 175(1):150-6. PubMed ID: 26918554
[TBL] [Abstract][Full Text] [Related]
15. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
Hosaka H; Ohtoshi S; Nakada T; Iijima M
J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
[TBL] [Abstract][Full Text] [Related]
16. A rare case of isoniazid-induced erythroderma.
Garg Y; Gore R; Jain S; Kumar A
Indian J Pharmacol; 2015; 47(6):682-4. PubMed ID: 26729965
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome during anti-tuberculosis chemotherapy in HIV-seropositive patients: report on six cases.
Wirima JJ; Harries AD
East Afr Med J; 1991 Jan; 68(1):64-6. PubMed ID: 2060484
[TBL] [Abstract][Full Text] [Related]
18. Optic neuritis with concurrent etanercept and isoniazid therapy.
Noguera-Pons R; Borrás-Blasco J; Romero-Crespo I; Antón-Torres R; Navarro-Ruiz A; González-Ferrandez JA
Ann Pharmacother; 2005 Dec; 39(12):2131-5. PubMed ID: 16264061
[TBL] [Abstract][Full Text] [Related]
19. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
[TBL] [Abstract][Full Text] [Related]
20. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
